SD-101: Completed Phase IIb enrollment

Scioderm completed enrollment of 48 patients ages >=6 months with simplex, recessive dystrophic or junctional epidermolysis bullosa in the double-blind, placebo-controlled, U.S. Phase IIb SD-003 trial...